Crowdstake

Multidisciplinary Association for Psychedelic Studies

EIN: 59-2751953 · San Jose, CA

Psychedelic Research
PTSD Treatment
Education and Advocacy

Transforming Mental Health Through Psychedelic Research

The Multidisciplinary Association for Psychedelic Studies, commonly known as MAPS, is at the forefront of a groundbreaking movement to integrate psychedelics into mainstream medicine. Founded in 1986, MAPS is dedicated to the research and development of psychedelic substances for therapeutic use, aiming to alleviate suffering from various mental health conditions. With a focus on rigorous scientific research, MAPS is committed to ensuring that these powerful substances are used safely and effectively.

Impacting Lives Through Research

MAPS has made significant strides in the field of psychedelic research, particularly in the treatment of PTSD, anxiety, and depression. The organization has conducted numerous clinical trials, demonstrating the potential of substances like MDMA and psilocybin to provide relief where traditional therapies have failed. By collaborating with leading researchers and institutions, MAPS is paving the way for a new era of mental health treatment.

Why Donate to MAPS?

Your contributions to MAPS directly support vital research initiatives that have the potential to change lives. Donations help fund clinical trials, educational programs, and advocacy efforts aimed at promoting the safe and responsible use of psychedelics. By donating, you are not only supporting scientific advancement but also contributing to a future where mental health care is accessible and effective for all.

Join the Movement

Every donation, whether in cryptocurrency or cash, plays a crucial role in advancing MAPS' mission. Together, we can help unlock the therapeutic potential of psychedelics and transform the landscape of mental health treatment.

Donate today to support MAPS and be part of this revolutionary journey!

Do you represent Multidisciplinary Association for Psychedelic Studies? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.